DTSRF yields 75.47% · PFE yields 6.20%● Live data
📍 DTSRF pulled ahead of the other in Year 1
Combined, DTSRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DTSRF + PFE for your $10,000?
The fund invests directly in ether that are held securely in cold storage while seeking to benefit from staking. Staking refers to the proof-of-stake consensus protocols that ensure transactions are properly recorded on a blockchain. The process allows owners of a cryptocurrency to validate block transactions through validators that verify the accuracy of recorded data. In return, validators are rewarded with digital assets. For the fund, rewards are paid in ether and will depend on the amount of ether staked. Staked ether serve as collateral that are locked in the network but are at risk of loss if validators fail to meet network rules. The fund manager selects and directs experienced sub-custodians as validators for staking activities. In addition, the fund manager has discretion in the amount of staked ether from the portfolio. The ETF does not intend to use derivatives or employ leverage to acquire ether. It may also hold cash, cash equivalents or other money market instruments.
Full DTSRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.